- When the fundamentals of a company:
- Are strong
- Demonstrate a good probability of disrupting the norm (I.e. standard of care in oncology)
- Show a solid cash reserve
- Have multiple products that could apply to point 2
- Have an experienced and renowned leadership team
Yet the share price is relatively low…
An opportunity presents itself. I am taking this opportunity to buy.
Ann: New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUS, page-61
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.1¢ |
Change
-0.003(4.69%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 6.4¢ | 6.5¢ | 6.1¢ | $1.001M | 15.83M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 3089082 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 1840735 | 21 |
View Market Depth
| Last trade - 12.04pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.2¢ |
Change
-0.003 ( 3.91 %) |
||||
| Open | High | Low | Volume | ||
| 6.4¢ | 6.5¢ | 6.1¢ | 11109162 | ||
| Last updated 12.19pm 04/06/2024 ? | |||||
| IMU (ASX) Chart |